Anthelmintic Drugs Global Market Report 2024

Description

Anthelmintic drugs are medications designed to treat infections caused by parasitic worms, or helminths. These drugs function by either killing the worms directly or disrupting their reproductive capabilities. They are commonly prescribed for conditions such as roundworm, tapeworm, and hookworm infections.

The primary classes of anthelmintic drugs include benzimidazoles, macrocyclic lactones, pyrazinoisoquinolones, tetrahydropyrimidines, and others. Benzimidazoles are a group of organic compounds featuring a benzene ring fused with an imidazole ring. They are utilized in various applications, including as pharmaceutical agents for treating parasitic infections and as key components in some synthetic materials. These drugs can be administered orally or via injection to treat a range of infections, including nematode, cestode, trematode, and mixed infections. They are distributed through multiple channels, such as hospitals and clinics, retail pharmacies, online pharmacies, and veterinary clinics and supply stores, and are used in both human and veterinary anthelmintics.

The anthelmintic drugs market research report is one of a series of new reports from The Business Research Company that provides anthelmintic drugs market statistics, including the anthelmintic drugs industry's global market size, regional shares, competitors with an anthelmintic drugs market share, detailed anthelmintic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anthelmintic drugs industry. This anthelmintic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The anthelmintic drugs market size has grown strongly in recent years. It will grow from $3.00 billion in 2023 to $3.16 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth during the historic period can be attributed to several factors such as the high prevalence of helminth infections, increased public health initiatives, rising pharmaceutical research and development, greater awareness and education, and overall economic growth.

The anthelmintic drugs market size is expected to see strong growth in the next few years. It will grow to $3.90 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The growth during the forecast period can be attributed to several factors such as the rising incidence of parasitic infections worldwide, increased use of anthelmintics in livestock and pets, growing awareness and health initiatives, and more frequent international travel. Key trends expected during this period include a rising demand for combination therapies, a heightened focus on managing drug resistance, growing adoption of personalized medicine, expansion of telemedicine for treatment monitoring, increased research on novel drug targets, and an emphasis on preventive healthcare measures.

The high prevalence of parasitic infections is anticipated to drive the growth of the anthelmintic drugs market in the future. Parasitic infections are diseases caused by organisms that live on or inside a host, such as protozoa, worms, or ectoparasites. These infections are exacerbated by factors such as poor sanitation, contaminated food or water, close contact with infected individuals or animals, inadequate hygiene, and lack of access to clean resources. Anthelmintic drugs are used to treat infections caused by parasitic worms by targeting and eliminating these parasites from the host's body. These medications disrupt the physiological functions of the parasites, leading to their expulsion or death. For example, in July 2023, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported a twofold increase in cyclosporiasis cases in Florida, from 254 cases in 2021 to 513 cases in 2022. Thus, the high prevalence of parasitic infections is fueling the growth of the anthelmintic drugs market.

Leading companies in the anthelmintic drugs market are focusing on developing innovative combination drugs to offer comprehensive protection against multiple parasites. Combination anthelmintic drugs are formulations that blend two or more anthelmintic agents to enhance efficacy against parasitic infections in both humans and animals. These drugs work synergistically to expand the range of activity, delay the onset of drug resistance, and address existing resistance in parasites. For instance, in January 2022, Zoetis Inc., a US-based animal health company, received approval from the U.S. Food and Drug Administration for Simparica Trio, a new label indication that allows it to prevent infections caused by Borrelia burgdorferi, which causes Lyme disease in dogs. Simparica Trio combines three active ingredients-sarolaner, moxidectin, and pyrantel-to provide broad protection against fleas, ticks, heartworms, roundworms, and hookworms.

In July 2023, Bayer AG, a Germany-based pharmaceutical and biotechnology company, partnered with the Swiss Tropical and Public Health Institute (Swiss TPH) to develop anthelmintic drug compounds for treating parasitic infections. This collaboration aims to assess the safety and efficacy of emodepside, a compound originally developed for veterinary use, for treating soil-transmitted helminths in humans. The goal is to provide a new treatment option and advance global health efforts by addressing a major public health challenge in developing regions. The Swiss Tropical and Public Health Institute (Swiss TPH) is a Switzerland-based research institute focused on global health and tropical diseases.

Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company

North America was the largest region in the anthelmintic drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anthelmintic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anthelmintic drugs market consists of sales of albendazole, mebendazole, praziquantel, levamisole, piperazine, and ivermectin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anthelmintic Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anthelmintic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anthelmintic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anthelmintic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Benzimidazoles; Macrocyclic lactones; Pyrazinoisoquinolones; Tetrahydropyrimidines; Other Drug Classes
2) By Route Of Administration: Oral; Injectable
3) By Infection Type: Nematode Infections; Cestode Infections; Trematode Infections; Mixed Infections
4) By Distribution Channel: Hospitals And Clinics; Retail Pharmacies; Online Pharmacies; Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics; Veterinary Anthelmintics
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20446

1. Executive Summary

2. Anthelmintic Drugs Market Characteristics

3. Anthelmintic Drugs Market Trends And Strategies

4. Anthelmintic Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Anthelmintic Drugs Market Size and Growth

5.1. Global Anthelmintic Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Anthelmintic Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Anthelmintic Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Anthelmintic Drugs Market Segmentation

6.1. Global Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Benzimidazoles
Macrocyclic lactones
Pyrazinoisoquinolones
Tetrahydropyrimidines
Other Drug Classes
6.2. Global Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Injectable
6.3. Global Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Nematode Infections
Cestode Infections
Trematode Infections
Mixed Infections
6.4. Global Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Retail Pharmacies
Online Pharmacies
Veterinary Clinics And Supply Stores
6.5. Global Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Human Anthelmintics
Veterinary Anthelmintics

7. Anthelmintic Drugs Market Regional And Country Analysis

7.1. Global Anthelmintic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Anthelmintic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Anthelmintic Drugs Market

8.1. Asia-Pacific Anthelmintic Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Anthelmintic Drugs Market

9.1. China Anthelmintic Drugs Market Overview
9.2. China Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Anthelmintic Drugs Market

10.1. India Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Anthelmintic Drugs Market

11.1. Japan Anthelmintic Drugs Market Overview
11.2. Japan Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Anthelmintic Drugs Market

12.1. Australia Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Anthelmintic Drugs Market

13.1. Indonesia Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Anthelmintic Drugs Market

14.1. South Korea Anthelmintic Drugs Market Overview
14.2. South Korea Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Anthelmintic Drugs Market

15.1. Western Europe Anthelmintic Drugs Market Overview
15.2. Western Europe Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Anthelmintic Drugs Market

16.1. UK Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Anthelmintic Drugs Market

17.1. Germany Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Anthelmintic Drugs Market

18.1. France Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Anthelmintic Drugs Market

19.1. Italy Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Anthelmintic Drugs Market

20.1. Spain Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Anthelmintic Drugs Market

21.1. Eastern Europe Anthelmintic Drugs Market Overview
21.2. Eastern Europe Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Anthelmintic Drugs Market

22.1. Russia Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Anthelmintic Drugs Market

23.1. North America Anthelmintic Drugs Market Overview
23.2. North America Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Anthelmintic Drugs Market

24.1. USA Anthelmintic Drugs Market Overview
24.2. USA Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Anthelmintic Drugs Market

25.1. Canada Anthelmintic Drugs Market Overview
25.2. Canada Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Anthelmintic Drugs Market

26.1. South America Anthelmintic Drugs Market Overview
26.2. South America Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Anthelmintic Drugs Market

27.1. Brazil Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Anthelmintic Drugs Market

28.1. Middle East Anthelmintic Drugs Market Overview
28.2. Middle East Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Anthelmintic Drugs Market

29.1. Africa Anthelmintic Drugs Market Overview
29.2. Africa Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Anthelmintic Drugs Market Competitive Landscape And Company Profiles

30.1. Anthelmintic Drugs Market Competitive Landscape
30.2. Anthelmintic Drugs Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Anthelmintic Drugs Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Novartis AG
31.3. GlaxoSmithKline plc
31.4. Boehringer Ingelheim International GmbH
31.5. Teva Pharmaceutical Industries Limited
31.6. Zoetis Inc.
31.7. Hetero Labs Limited
31.8. Sun Pharmaceutical Industries Ltd.
31.9. Galderma S.A.
31.10. Cipla Inc.
31.11. Ferring Pharmaceuticals Inc.
31.12. Amneal Pharmaceuticals, Inc.
31.13. Zydus Lifesciences Limited
31.14. Glenmark Pharmaceuticals Ltd.
31.15. Mankind Pharma Ltd.

32. Global Anthelmintic Drugs Market Competitive Benchmarking

33. Global Anthelmintic Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Anthelmintic Drugs Market

35. Anthelmintic Drugs Market Future Outlook and Potential Analysis

35.1 Anthelmintic Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Anthelmintic Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Anthelmintic Drugs Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer